Marker Therapeutics (NASDAQ:MRKR) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Marker Therapeutics (MRKR) operate in?

Marker Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Marker Therapeutics Stock (NASDAQ: MRKR) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 80.38K
Day Range	- - -
52 Wk Range	1.48 - 5.99
Market Cap	$17.45M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	2.82%
Days to Cover	2.26

Recent News

Cancer Cell Therapy Focused Marker Therapeutics Announces Pipeline Prioritization

Marker Therapeutics Inc (NASDAQ: MRKR) announced it is restructuring its clinical programs and strategic prioritization of its multi-tumor associated antigen (multiTAA)-specific T cell product pipeline.

Vandana Singh

Why Is Blood Cancer Focused Marker Therapeutics Stock Trading Higher Today?

Marker Therapeutics Inc (NASDAQ: MRKR) released the preliminary results of the first participant treated with MT-601, its multi-tumor associated antigen (multiTAA)-specific T cell product targeting 6 TAAs, in the Phase 1 multicenter

Vandana Singh

Why Avantax Shares Are Trading Higher By Over 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Gainers Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) jumped 76% to $28.13 after the company's once-daily oral paltusotine achieved the primary and secondary endpoints in the Phase 3 PATHFNDR-1 study in acromegaly.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	0 / 80.38K
Day Range	- - -
52 Wk Range	1.48 - 5.99
Market Cap	$17.45M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	2.82%
Days to Cover	2.26

About Marker Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Marker Therapeutics (MRKR) stock?

You can purchase shares of Marker Therapeutics (NASDAQ:MRKR) through any online brokerage.

View our list of the best stock brokerages

Who are Marker Therapeutics (MRKR) competitors?

Other companies in Marker Therapeutics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), NKGen Biotech (NASDAQ:NKGN), CARISMA Therapeutics (NASDAQ:CARM), Cellectar Biosciences (NASDAQ:CLRB) and Evaxion Biotech (NASDAQ:EVAX).

What is the forecast, or price target, for Marker Therapeutics (MRKR) stock?

Marker Therapeutics has a consensus price target of $19.00.

What is the current price for Marker Therapeutics (MRKR)?

The stock price for Marker Therapeutics (NASDAQ: MRKR) is $1.63 last updated February 20, 2025 at 4:00 PM EST.

Does Marker Therapeutics (MRKR) pay a dividend?

There are no upcoming dividends for Marker Therapeutics.

When is Marker Therapeutics (NASDAQ:MRKR) reporting earnings?

Marker Therapeutics’s Q1 earnings are confirmed for Wednesday, May 14, 2025.

Is Marker Therapeutics (MRKR) going to split?

There is no upcoming split for Marker Therapeutics.

What sector and industry does Marker Therapeutics (MRKR) operate in?

Marker Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Marker Therapeutics

Marker Therapeutics (MRKR) Forecast